• CACVS
  • CACVS
  • CACVS
  • CACVS
  • CACVS
  • CACVS
  
     

Saturday January 19 / Auditorium, level -1

   
  Moderators
08.00
    M. Bosiers, R. Hassen-Khodja
Miscellanous
  08.00     Should we stop Clopidrogrel before open vascular surgery?, C. Saadeh
  08.10     Myocardial infarction following vascular surgery: why should we take it seriousl?
P. Schneider
  08.20     Carotid
  08.20     Which asymptomatic stenosis are at risk of stroke?, S. Kakkos
  08.30     Watershed infarct: do they influence the results of carotid surgery?, E. Jean-Baptiste
  08.40     Discussion
  08.50     Controversy: CEA and CAS
  08.50     CEA is Superior to CAS: an EBM conclusion, A. Stella  
  09.00     CEA is not superior to CAS: we simply do not have the answer yet, A. W. Hallyday  
  09.10
09.10
09.20

    Can we improve the results of CAS?
What the recent data of CAS versus CEA tell us, S. Macdonald
Discussion
  09.30
09.30
    CAS: what factors should be taken into account
High volume versus low volume centers, P. Cao
  09.40     Early treatment after onset of symptoms, G. Fraedrich
  09.50
10.00
    Proximal protection devices, A. Cremonesi
Discussion
         
  10.10     Break in the exhibition hall
         
  10.40     More on short or no neck aneurysms
  Moderators
    F. J. Veith, E. Verhoeven, M. Malina, A. Khayati
 
10.40
10.50
11.00
11.10
    Controversy: Open repair or endo repair
FEVAR is the current gold standard, I. Loftus
Open surgery is the only proven procedure, J-B. Ricco
Which patients should not be treated endo, X. Chaufour
Discussion
  11.00

11.15

11.45

12.00



    ePosters competition
Jury members P. Desgranges & R. Hassen Khodja
Clinical cases
presented by J-P. Becquemin
discussed by P. Cao, N. Cheshire, L. Chiche, H-H. Eckstein, M. Malina, F. J. Veith
Honorary guest lecture: the evolution of endovascular therapy and its impact on the future, E. Diethrich
Industry symposia

        

         
  13.00     Lunch in the exhibition hall
         
  Moderators     J. Brunkwall, E. Ducasse, P. Kasprzak
        New technology for short and no neck aneurysm        
  14.00     Urgent need: how to customize a fenestrated graft in 2 hours, F. Cochennec
  14.10     Off the shelf stent graft for TAAA, S. Haulon
  14.20     The Ventana device: one device fits all, J-P. Becquemin       
  14.30     The Anaconda device, P. Bungay
  14.40     Multilayer flow: too good to be true? Principles, E. Diethrich        
  14.50     Multilayer flow: too good to be true? Clinical results, C. Vaislic
  15.00     Fenestrated and branched graft around the globe: what are the pieces of evidence     
  15.00     GB the BESET registry, R. S. Vallabhaneni
  15.10     France: The Windows 1, 2 and 3 studies, J-P. Becquemin
  15.20     USA: 10 years experience of the Cleveland clinic: are we up to the goal, T. Mastracci  
  15.30     Fate of visceral stents in F and B stent grafts, P. Kasprzak     
  15.40     Discussion
  15.50     AAA rupture the old enemy is still there: is Endo the wrong choice?
  15.50     Disappointment from the Ajax trial: no benefit from rEVAR, A. C. Vahl                     
  16.00     Results worse than expected what is the problem, D. Mayer
  16.10     Rupture with no neck is not a contra indication for EVAR, M. Malina
  16.20     Discussion
  16.30
16.30
16.40
16.50
    Controversy: ruptured AAA treatment
Fix it rapidly by an open repair: it is the safest way, J. Schmidli
EVAR is better than open repair: do not believe figures, F. J. Veith
Discussion
  17.00     Adjournment